Latham & Watkins advised Anima in the transaction. AbbVie (NYSE: ABBV) and Anima Biotech (Anima) have announced a collaboration to discover and develop mRNA biology modulators...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here